Early diagnosis and prompt targeted therapy are essential for septic patients' outcome. Procalcitonin (PCT) has been shown to predict bacteraemia and bacterial DNAaemia. Presepsin, the circulating soluble form of CD14 subtype, increases in response to bacterial infections, and is considered a new, emerging, early marker for sepsis. We evaluated the diagnostic accuracy of presepsin in predicting bacteraemia and bacterial DNAaemia in 92 patients with suspected sepsis, and we compared it with that of PCT and C-reactive protein (CRP). Presepsin median values were significantly higher in bacteraemic vs non-bacteraemic patients [1290 pg ml .07, respectively). Both biomarkers performed significantly better than CRP, which had an AUC for bacteraemia of 0.602 and for DNAaemia of 0.632 (all P values <0.05). In conclusion, in patients with suspected sepsis, presepsin and PCT showed a good diagnostic accuracy in predicting both bacteraemia and bacterial DNAaemia, superior to CRP.
INTRODUCTIONSepsis, a systemic deleterious host response to infection that leads to organ dysfunction (Dellinger et al., 2013), is a major cause of morbidity and mortality (Mayr et al., 2014). Early diagnosis and prompt targeted therapy are essential for patients' outcome (Kumar et al., 2006).Blood culture (BC) is the gold standard for pathogen detection, although false-negative results, especially in antibiotic pre-treated patients, can occur (Opota et al., 2015). New approaches to speed sepsis diagnosis include molecular assays and the use of specific biomarkers (Reinhart et al., 2012). Molecular technologies, allowing a rapid detection of microbial DNA, could represent an important additional tool for the aetiological diagnosis of bloodstream infections, particularly in antibiotic pre-treated patients (Dark et al., 2015;Mongelli et al., 2015;Pasqualini et al., 2012). Indeed, real-time PCR (RT-PCR) can detect not only viable microorganisms in patient's blood (bacteraemia) but also circulating bacterial DNA (DNAaemia) that persists for several days in blood during antimicrobial treatment or may be released into the bloodstream from the primary infectious foci (Øvstebø et al., 2004;Navarro et al., 2006;Peters et al., 2007).During recent years, many biomarkers have been evaluated and compared to find the best predictor of sepsis (Cho & Choi, 2014). Procalcitonin (PCT) has been identified as having a good diagnostic accuracy for predicting bacteraemia and pathogen DNAaemia in different clinical settings (Koivula et al., 2011;Mencacci et al., 2012), representing an advance over C-reactive protein (CRP) (Barati et al., 2008;Leli et al., 2014;Yu et al., 2010 Rabensteiner et al., 2014;Romualdo et al., 2014;Shozushima et al., 2011).To the best of our knowledge, no study described presepsin diagnostic accuracy in predicting both bacteraemia and bacterial DNAaemia, which was the first aim of this study.The second aim was to compare the diagnostic accuracy of presepsin with that of PCT and CRP.
METHODSPatients and samples. This prospective observational stud...